Greater Phillys largest health insurer to restrict coverage for weight loss medications, citing exorbitant costs Independence Blue Cross joins other insurance companies in restricting coverage of Wegovy and Ozempic to Type 2 diabetes and heart disease
The pH, ionic strength, and perhaps even chemical reactions within the formulation might cause faster degradation of the semaglutide peptide, thereby reducing its BUD still further
Patients who maintain a regular exercise routine, manage their stress levels, and get enough sleep are more likely to see sustained results
Comparing OCT scans and photographs from different dates reveals trends that guide our treatment decisions
When combined with proper medication storage and expiration awareness, genetic insights can help your healthcare team build a personalized GLP-1 protocol that maximizes efficacy
The program runs through December 31, 2027